Danaher Corporation (DHR) Shares Bought by Arrow Financial Corp
Arrow Financial Corp increased its stake in Danaher Corporation (NYSE:DHR) by 2.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,264 shares of the conglomerate’s stock after purchasing an additional 51 shares during the quarter. Arrow Financial Corp’s holdings in Danaher Corporation were worth $191,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in DHR. Peddock Capital Advisors LLC increased its holdings in shares of Danaher Corporation by 17.4% in the 1st quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 181 shares in the last quarter. Proficio Capital Partners LLC increased its holdings in shares of Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares in the last quarter. ClariVest Asset Management LLC purchased a new position in shares of Danaher Corporation in the 1st quarter valued at about $157,000. Cornerstone Advisors Inc. increased its holdings in shares of Danaher Corporation by 62.0% in the 2nd quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock valued at $178,000 after purchasing an additional 808 shares in the last quarter. Finally, Baystate Wealth Management LLC increased its holdings in shares of Danaher Corporation by 11.3% in the 2nd quarter. Baystate Wealth Management LLC now owns 2,115 shares of the conglomerate’s stock valued at $181,000 after purchasing an additional 215 shares in the last quarter. Institutional investors and hedge funds own 75.75% of the company’s stock.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the sale, the director now owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider William King sold 43,688 shares of the business’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the sale, the insider now owns 45,748 shares in the company, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 71,496 shares of company stock worth $5,916,223. Corporate insiders own 12.20% of the company’s stock.
DHR has been the subject of a number of research analyst reports. Credit Suisse Group reiterated a “buy” rating and issued a $93.00 price target on shares of Danaher Corporation in a report on Wednesday, May 24th. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Thursday, June 15th. Zacks Investment Research downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Finally, Deutsche Bank AG reiterated a “buy” rating and issued a $97.00 price target on shares of Danaher Corporation in a report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Danaher Corporation has an average rating of “Buy” and a consensus price target of $92.72.
Shares of Danaher Corporation (DHR) opened at 88.21 on Friday. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.48. The company has a 50-day moving average of $82.64 and a 200-day moving average of $84.22. The firm has a market capitalization of $61.28 billion, a PE ratio of 28.16 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.90 earnings per share. On average, equities analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.14 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.63%. Danaher Corporation’s payout ratio is presently 17.83%.
ILLEGAL ACTIVITY WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/09/17/danaher-corporation-dhr-shares-bought-by-arrow-financial-corp.html.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.